Implantable Neurostimulation Devices Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Implantable Neurostimulation Devices Market?
In the past years, a substantial increase has been observed in the market size of implantable neurostimulation devices. The market which was valued at $8.68 billion in 2024 is projected to rise to $9.64 billion in 2025 boasting a compound annual growth rate (CAGR) of 11.1%. A surge in the demand for non-pharmacological treatments, an increase in the advocacy for less invasive procedures, a growing aged population, an escalating number of psychiatric disorders and a rising prevalence of chronic diseases are some reasons that have fueled the growth in the past period.

Predictions for the implantable neurostimulation devices market indicate that it will witness a substantial increase in the coming years. The market is estimated to reach $14.53 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to this projected growth during the forecast period include an uptick in neurological disorders, the burgeoning of lifestyle diseases, enhanced awareness, a climb in spinal cord injuries, and a surge in healthcare spending. Trend highlights for the same period reflect sensing technology, advancements in neurostimulation technologies, technologically sophisticated products, the incorporation of closed-loop systems, and the inclusion of wireless technology.

What Factors Are Propelling the Expansion of the Implantable Neurostimulation Devices Market?
The implantable neurostimulation device market is forecasted to grow due to the increasing occurrence of neurological disorders. Neurological disorders are any conditions that impact the structure or function of the nervous system, leading to a range of symptoms like paralysis, seizures, and cognitive impairments. Greater exposure to risk factors such as high blood pressure, developmental abnormalities, trauma, or injury results in increased detection rates of these disorders. Implantable neurostimulation devices, which are utilized when other treatments are not sufficient or effective, adjust nerve activity and alleviate symptoms. For example, the Alzheimer's Association, a US-based voluntary health organization, estimates that by 2024, 6.9 million Americans aged 65 and older will be living with Alzheimer's disease, 73% of whom are set to be age 75 or older. By 2050, this figure is expected to rise to 12.7 million. As a result, the escalating prevalence of neurological disorders is set to fuel the growth of the implantable neurostimulation device market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp

Which Businesses Are at the Forefront of Implantable Neurostimulation Devices Market Development?
Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

What Are the Latest Innovations in the Implantable Neurostimulation Devices Market?
Market leaders in the implantable neurostimulation devices segment are prioritizing the creation of technologically upgraded products, such as spinal cord stimulation (SCS) systems, to provide relief from chronic pain. The function of a spinal cord stimulation (SCS) system is to use electrical impulses to regulate nerve activities in the spinal cord, which is effective in alleviating chronic pain and enhancing the quality of life when other treatments fail. For example, Abbott, a medical device firm based in the US, made public its approval from the U.S. Food and Drug Administration (FDA) for the Eterna spinal cord stimulation (SCS) system in December 2022. The smallest implantable, rechargeable spinal cord stimulator in the market, Eterna SCS, has been designed for maximum comfort throughout the day. It is equipped with Abbott's exclusive BurstDR stimulation technology which imitates natural brain firing patterns for superior pain control and it is favored by 87% of patients over the traditional sensation of tingling. Its recharging needs are the least in the market, potentially requiring only five recharges each year because of Xtend energy technology, making Eterna highly convenient. The TotalScan technology makes full-body MRI scans possible and it is adaptable to future innovative developments without needing replacement. Moreover, Abbott has inbuilt mobile application integration that allows patients to monitor battery life and charging status in real time on iPhone devices.

How Is the Implantable Neurostimulation Devices Market Segmented?
The implantable neurostimulation devicesmarket covered in this report is segmented -

1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
2) By Application: Pain Management, Parkinson's Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers

Subsegments:
1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices
2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators
3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression
6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/implantable-neurostimulation-devices-global-market-report

Where Is the Implantable Neurostimulation Devices Market Growth Most Prominent?
North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Implantable Neurostimulation Devices Global Market Report?

- Market Size Analysis: Analyze the Implantable Neurostimulation Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Implantable Neurostimulation Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Implantable Neurostimulation Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Implantable Neurostimulation Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19520

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.